ARMP

Armata Pharmctcl

• NASDAQ·4d ago

  Krystal Biotech, Inc. (KRYS) Surpasses Q3 Earnings and Revenue Estimates

• Seeking Alpha·10/29 19:44

  Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens

• TipRanks·10/07 11:06

  Armata announces two new patents covering bacteriophage programs

• TipRanks·09/27 14:35

  JonesTrading Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)

• Dow Jones·09/23 15:04

  Armata Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

• Dow Jones·09/23 11:45

  Armata Gets $3.7M in Additional Funding From Defense Dept. for Bacterial Infection Treatment

• TipRanks·09/23 11:28

  Armata secures new U.S. funding for AP-SA02 Phase 3

• TipRanks·09/23 11:05

  Armata Pharmaceuticals receives $3.7M in additional funding from DoW

• PR Newswire·09/23 11:00

  Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development

• TipRanks·09/22 10:40

  Analysts Offer Insights on Healthcare Companies: RxSight (RXST) and Armata Pharmaceuticals (ARMP)

• PR Newswire·09/21 11:00

  Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates

• Dow Jones·09/14 12:47

  Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment

• NASDAQ·09/14 12:22

  Armata Wins FDA Breakthrough Therapy Designation For AP-SA02 In Complicated SAB; Stock Up

• TipRanks·09/14 11:27

  Armata wins FDA Breakthrough Therapy for AP-SA02

• PR Newswire·09/10 11:00

  Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference